" class="no-js "lang="en-US"> Vensica Therapeutics - Medtech Alert
Wednesday, October 15, 2025
Vensica Therapeutics | Pharmtech Focus

Vensica Therapeutics

About Vensica Therapeutics

Vensica Therapeutics

Vensica Medical is a medical device company that is designing and developing and Ultrasound catheter for the treatment of bladder cancer.
Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).
Using Vensica’s device, the drug will be instilled in a quick, pain-free procedure subsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.

Related Story

Vensica Therapeutics Closes $16 Million Investment Round

November 1 2021

Vensica Therapeutics (“Vensica”), a clinical stage biopharmaceutical company, announced that it has closed an investment round […]